|
1
|
Hu C, Dong X, Wu J, Xiao F, Shang J, Liu L, Yang Y, Luo D, Li Q, Song Q, Yang J, Zhang C, Shen L, Luo Z. CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: evidence from original research and literature. Oncotarget 2018; 8:30888-30899. [PMID: 28427166 PMCID: PMC5458175 DOI: 10.18632/oncotarget.15737] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Accepted: 02/06/2017] [Indexed: 01/30/2023] Open
Abstract
Gastric cancer (GC) is one of the most common malignancies worldwide. The expression of CD147 protein is associated with GC. However, the clinical role of CD147 in GC has not been investigated extensively. Hence, we focused on studying the association between the expression of CD147 and clinicopathological features of GC patients in this study. Firstly, sixteen publications (1752 cases and 391 controls) and one from our own original research (143 cases) were included in the meta-analysis to obtain a more precise estimation of the diagnostic value of CD147. The results showed that expression rate of CD147 in the GC group is higher than that in control group. Moreover, gender, TNM stage, lymph node metastasis, and depth of invasion are all associated with CD147. Further, sections of gastric tissue from 143 cases underwent immunohistochemical staining for evaluation of CD147 protein expression. Our retrospective analysis demonstrated CD147 protein expression was significantly associated with clinical N stage, and tumor stage. Meanwhile, it can also serve as an independent prognosis biomarker. In conclusion, our results support the role of CD147 as a good indicator of diagnosis and prognosis.
Collapse
Affiliation(s)
- Chenghao Hu
- Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, PR China
| | - Xiaoxia Dong
- Department of Pharmacology, School of Basic Medicine, Hubei University of Medicine, Shiyan, Hubei, PR China
| | - Junbo Wu
- Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, PR China
| | - Feifan Xiao
- First Clinical Academy, Guangxi Medical University, Nanning, Guangxi, PR China
| | - Jun Shang
- Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China
| | - Liang Liu
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, PR China
| | - Yuan Yang
- School of Life Sciences, Fudan University, Shanghai, PR China
| | - Dongmei Luo
- School of Mathematics and Physics, Anhui University of Technology, Maanshan, Anhui, PR China
| | - Qiuting Li
- Department of Clinical Oncology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
| | - Qian Song
- First Clinical Academy, Guangxi Medical University, Nanning, Guangxi, PR China
| | - Jingcheng Yang
- School of Life Sciences, Fudan University, Shanghai, PR China
| | - Chengdong Zhang
- School of Life Sciences, Fudan University, Shanghai, PR China
| | - Li Shen
- Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, PR China
| | - Zhiguo Luo
- Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, PR China
| |
Collapse
|
|
2
|
Liu XL, Chen HL, Yu BP, Guo MW, Li L. Significance of expression of EMMPRIN and MT1-MMP in primary gastric carcinoma and associated lymph node metastases. Shijie Huaren Xiaohua Zazhi 2012; 20:27-33. [DOI: 10.11569/wcjd.v20.i1.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and membrane-type matrix metalloproteinase-1 (MT1-MMP) proteins in primary gastric carcinoma (GC) and associated lymph node metastases, and to analyze their correlation with clinicopathologic parameters of GC.
METHODS: Expression of EMMPRIN and MT1-MMP proteins were detected by quantum dot-based immunofluorescence technology on tissue microarrays including 204 cases of GC, 21 cases of non-cancerous gastric mucosa tissue, and 20 cases of metastatic lymph node tissue. The results were analyzed using a semiquantitative method.
RESULTS: The positive rates of EMMPRIN and MT1-MMP protein expression were highest metastatic lymph nodes, followed by GC, chronic atrophic gastritis with intestinal metaplasia, and normal gastric mucosa, which showed a decreasing trend. The positive rates of EMMPRIN and MT1-MMP protein expression were significantly higher in GC and lymph node metastases than in normal gastric mucosa. The expression of EMMPRIN protein was positively correlated with infiltration depth, higher TNM stage and lymph node metastasis, while expression of MT1-MMP protein was positively correlated with higher TNM stage and lymph node metastasis. A positive correlation was observed between EMMPRIN and MT1-MMP protein expression in GC (r = 0.584, P = 0.001).
CONCLUSION: EMMPRIN and MT1-MMP proteins may play a synergistic role in the development and progression of GC.
Collapse
|